Suchergebnisse - "Sarilumab"

PubPharm (39)

1

Cancer risk with tocilizumab/sarilumab, abatacept, and rituximab treatment in patients with rheumatoid arthritis : a Danish cohort study

enthalten in: Rheumatology (Oxford, England) | 2024

von Westermann, R. | Cordtz, R. | Duch, K. | +4

2

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

3

Efficacy and safety of interleukin-6 receptor antagonists in adult patients admitted to intensive care unit with COVID-19 : A systematic review and meta-analysis of randomized controlled trials

enthalten in: Preventive medicine reports | 2023

von Peng, R. | Yang, T. | Tong, Y. | +7

4

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19 : a natural experiment due to drug shortages

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Swets, M. | Moss, R. | Kor, F. | +10

5

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gallagher, J. | Morgan, R.

CommentOn: Clin Microbiol Infect. 2023 Jan;29(1):13-21. - PMID 35863630

6

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids : a systematic review and meta-analysis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Albuquerque, A. | Eckert, I. | Tramujas, L. | +4

CommentIn: Clin Microbiol Infect. 2023 Jan;29(1):7-9. - PMID 36257548

7

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages

in: International Journal of Infectious Diseases | 2023

von Maaike C. Swets | Rob J. Moss | Flip Kor | +10

8

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

9

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

10

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5